These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19724896)

  • 1. Proteins and single nucleotide polymorphisms involved in apoptosis, growth control, and DNA repair predict cisplatin sensitivity in head and neck cancer cell lines.
    Farnebo L; Jedlinski A; Ansell A; Vainikka L; Thunell LK; Grénman R; Johansson AC; Roberg K
    Int J Mol Med; 2009 Oct; 24(4):549-56. PubMed ID: 19724896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining factors on protein and gene level to predict radioresponse in head and neck cancer cell lines.
    Farnebo L; Jerhammar F; Ceder R; Grafström RC; Vainikka L; Thunell L; Grénman R; Johansson AC; Roberg K
    J Oral Pathol Med; 2011 Nov; 40(10):739-46. PubMed ID: 21481002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA repair genes XPC, XPD, XRCC1, and XRCC3 are associated with risk and survival of squamous cell carcinoma of the head and neck.
    Farnebo L; Stjernström A; Fredrikson M; Ansell A; Garvin S; Thunell LK
    DNA Repair (Amst); 2015 Jul; 31():64-72. PubMed ID: 26001739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
    Quintela-Fandino M; Hitt R; Medina PP; Gamarra S; Manso L; Cortes-Funes H; Sanchez-Cespedes M
    J Clin Oncol; 2006 Sep; 24(26):4333-9. PubMed ID: 16896002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. XPD c.934G>A polymorphism of nucleotide excision repair pathway in outcome of head and neck squamous cell carcinoma patients treated with cisplatin chemoradiation.
    Lopes-Aguiar L; Costa EF; Nogueira GA; Lima TR; Visacri MB; Pincinato EC; Calonga L; Mariano FV; de Almeida Milani Altemani AM; Altemani JM; Coutinho-Camillo CM; Ribeiro Alves MA; Moriel P; Ramos CD; Chone CT; Lima CS
    Oncotarget; 2017 Mar; 8(10):16190-16201. PubMed ID: 26918827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strong expression of survivin is associated with positive response to radiotherapy and improved overall survival in head and neck squamous cell carcinoma patients.
    Farnebo L; Tiefenböck K; Ansell A; Thunell LK; Garvin S; Roberg K
    Int J Cancer; 2013 Oct; 133(8):1994-2003. PubMed ID: 23564498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associated risk of XRCC1 and XPD cross talk and life style factors in progression of head and neck cancer in north Indian population.
    Kumar A; Pant MC; Singh HS; Khandelwal S
    Mutat Res; 2012 Jan; 729(1-2):24-34. PubMed ID: 21945240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candidate apoptotic and DNA repair gene approach confirms involvement of ERCC1, ERCC5, TP53 and MDM2 in radiation-induced toxicity in head and neck cancer.
    Borchiellini D; Etienne-Grimaldi MC; Bensadoun RJ; Benezery K; Dassonville O; Poissonnet G; Llorca L; Ebran N; Formento P; Château Y; Thariat J; Milano G
    Oral Oncol; 2017 Apr; 67():70-76. PubMed ID: 28351583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced expression of DNA repair genes (XRCC1, XPD, and OGG1) in squamous cell carcinoma of head and neck in North India.
    Kumar A; Pant MC; Singh HS; Khandelwal S
    Tumour Biol; 2012 Feb; 33(1):111-9. PubMed ID: 22081374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The DNA damage response network in the treatment of head and neck squamous cell carcinoma.
    Psyrri A; Gkotzamanidou M; Papaxoinis G; Krikoni L; Economopoulou P; Kotsantis I; Anastasiou M; Souliotis VL
    ESMO Open; 2021 Apr; 6(2):100075. PubMed ID: 33714009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy.
    Sakano S; Wada T; Matsumoto H; Sugiyama S; Inoue R; Eguchi S; Ito H; Ohmi C; Matsuyama H; Naito K
    Br J Cancer; 2006 Sep; 95(5):561-70. PubMed ID: 16880786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.
    López-Cima MF; González-Arriaga P; García-Castro L; Pascual T; Marrón MG; Puente XS; Tardón A
    BMC Cancer; 2007 Aug; 7():162. PubMed ID: 17705814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting apoptosis to overcome cisplatin resistance: a translational study in head and neck cancer.
    Bauer JA; Kumar B; Cordell KG; Prince ME; Tran HH; Wolf GT; Chepeha DB; Teknos TN; Wang S; Eisbruch A; Tsien CI; Urba SG; Worden FP; Lee J; Griffith KA; Taylor JM; D'Silva N; Wang SJ; Wolter KG; Henson B; Fisher SG; Carey TE; Bradford CR
    Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S106-8. PubMed ID: 17848273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single nucleotide polymorphisms in DNA repair genes and the risk of laryngeal cancer: A meta-analysis.
    Li F; Wang J; Chen M
    Biomed Pharmacother; 2016 Mar; 78():92-100. PubMed ID: 26898429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of the Bcl-2/Bax status of head and neck cancer cell lines by chemotherapeutic agents.
    Kawakami K; Tsukuda M; Mizuno H; Nishimura G; Ishii A; Hamajima K
    Anticancer Res; 1999; 19(5B):3927-32. PubMed ID: 10628333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in human DNA repair genes and head and neck squamous cell carcinoma.
    Khlifi R; Rebai A; Hamza-Chaffai A
    J Genet; 2012; 91(3):375-84. PubMed ID: 23271025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
    Crowe DL; Sinha UK
    Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Gli1 results in altered c-Jun activation, inhibition of cisplatin-induced upregulation of ERCC1, XPD and XRCC1, and inhibition of platinum-DNA adduct repair.
    Kudo K; Gavin E; Das S; Amable L; Shevde LA; Reed E
    Oncogene; 2012 Nov; 31(44):4718-24. PubMed ID: 22266871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein levels of p21, p27, cyclin E and Bax predict sensitivity to cisplatin and paclitaxel in head and neck squamous cell carcinomas.
    Taguchi T; Kato Y; Baba Y; Nishimura G; Tanigaki Y; Horiuchi C; Mochimatsu I; Tsukuda M
    Oncol Rep; 2004 Feb; 11(2):421-6. PubMed ID: 14719078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Polymorphisms of XPC, XPD, XPG Genes and their Association with Radiotherapy Induced Toxicity among Head and Neck Cancer Patients: A Hospital Based Study from Maharashtra.
    Gudur AK; Kale SR; Gudur RA; Bhosale SJ; Datkhile KD
    Asian Pac J Cancer Prev; 2024 Jan; 25(1):191-199. PubMed ID: 38285784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.